IN2014DN06737A - - Google Patents

Info

Publication number
IN2014DN06737A
IN2014DN06737A IN6737DEN2014A IN2014DN06737A IN 2014DN06737 A IN2014DN06737 A IN 2014DN06737A IN 6737DEN2014 A IN6737DEN2014 A IN 6737DEN2014A IN 2014DN06737 A IN2014DN06737 A IN 2014DN06737A
Authority
IN
India
Prior art keywords
composition
formulated
present
administration
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Sadasivan Vidyasagar
Paul Okunieff
Lurong Zhang
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of IN2014DN06737A publication Critical patent/IN2014DN06737A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN6737DEN2014 2012-02-08 2013-02-08 IN2014DN06737A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596480P 2012-02-08 2012-02-08
PCT/US2013/025294 WO2013119917A1 (en) 2012-02-08 2013-02-08 Materials and methods for treating diarrhea

Publications (1)

Publication Number Publication Date
IN2014DN06737A true IN2014DN06737A (da) 2015-05-22

Family

ID=48948047

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6737DEN2014 IN2014DN06737A (da) 2012-02-08 2013-02-08

Country Status (15)

Country Link
US (4) US20140377374A1 (da)
EP (1) EP2812007B1 (da)
JP (1) JP6084238B2 (da)
KR (2) KR102262179B1 (da)
CN (1) CN104093410B (da)
AP (1) AP3941A (da)
AU (1) AU2013216871B2 (da)
BR (1) BR112014019350B1 (da)
CA (1) CA2863388C (da)
EA (1) EA034014B1 (da)
ES (1) ES2862392T3 (da)
HK (1) HK1204290A1 (da)
IN (1) IN2014DN06737A (da)
MX (1) MX368543B (da)
WO (1) WO2013119917A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6000253B2 (ja) 2010-09-24 2016-09-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 胃腸機能を改善するための材料および方法
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
EP3459540A1 (en) 2014-11-24 2019-03-27 Entrinsic Health Solutions, Inc. Amino acid compositions for the treatment of symptoms of disease
EP3522882A4 (en) 2016-10-04 2020-06-24 The University of Florida Research Foundation Incorporated AMINO ACID COMPOSITIONS AND USES THEREOF
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
KR20220046544A (ko) * 2019-06-12 2022-04-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 답즙산 설사를 치료하는 방법
KR20230019151A (ko) * 2020-06-02 2023-02-07 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 설사를 치료하기 위한 제형 및 방법
JP2023533617A (ja) 2020-07-02 2023-08-03 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド 水分補給を促進するための製剤およびその使用方法
US20240252580A1 (en) * 2021-05-28 2024-08-01 The Coca-Cola Company Amino acid hydration formulation and method of use
CN115531363B (zh) * 2021-06-30 2024-03-29 中国科学技术大学 预防、抑制或治疗轮状病毒感染的药物组合物及其用途
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JP3301646B2 (ja) * 1993-03-19 2002-07-15 シスメックス株式会社 幼若細胞測定用試薬
AU706195B2 (en) * 1995-04-14 1999-06-10 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US20030143293A1 (en) * 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
JP2004123642A (ja) 2002-10-04 2004-04-22 Shimizu Pharmaceutical Co Ltd 電解質組成物
DK175877B1 (da) 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP4811576B2 (ja) * 2005-03-31 2011-11-09 味の素株式会社 水分電解質補給飲料
JP4512013B2 (ja) 2005-09-07 2010-07-28 和光堂株式会社 液体飲料組成物及びその製造方法
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
JP6000253B2 (ja) 2010-09-24 2016-09-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 胃腸機能を改善するための材料および方法
MX361647B (es) * 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.

Also Published As

Publication number Publication date
MX2014009557A (es) 2014-11-10
HK1204290A1 (en) 2015-11-13
BR112014019350A8 (pt) 2017-07-11
EA201400827A1 (ru) 2014-12-30
JP2015506981A (ja) 2015-03-05
AU2013216871B2 (en) 2017-08-17
CA2863388C (en) 2020-11-17
CA2863388A1 (en) 2013-08-15
EP2812007A1 (en) 2014-12-17
ES2862392T3 (es) 2021-10-07
EP2812007A4 (en) 2015-09-09
AP3941A (en) 2016-12-16
BR112014019350A2 (da) 2017-06-20
AU2013216871A1 (en) 2014-09-11
US20140377374A1 (en) 2014-12-25
MX368543B (es) 2019-10-07
CN104093410A (zh) 2014-10-08
WO2013119917A1 (en) 2013-08-15
BR112014019350B1 (pt) 2020-09-24
US20210299076A1 (en) 2021-09-30
AP2014007916A0 (en) 2014-09-30
KR102262179B1 (ko) 2021-06-07
US20250073260A1 (en) 2025-03-06
JP6084238B2 (ja) 2017-02-22
EP2812007B1 (en) 2020-12-30
US20150297636A1 (en) 2015-10-22
KR20200105525A (ko) 2020-09-07
CN104093410B (zh) 2018-04-27
EA034014B1 (ru) 2019-12-19
KR20140120941A (ko) 2014-10-14

Similar Documents

Publication Publication Date Title
MX368543B (es) Composiciones para tratar diarrea inducida por rotavirus.
MX2013004061A (es) Analogos de ciclosporina.
MY187540A (en) Compounds active towards bromodomains
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
GB201106750D0 (en) Novel compounds
IN2015DN01156A (da)
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
HK1218560A1 (zh) 组成与方法
HK1220326A1 (zh) 基於网络微生物组成和方法
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
TN2015000278A1 (en) Autotaxin inhibitors
MX2011007930A (es) Conjugados de insulina cristalina.
PH12013500441A1 (en) Materials and methods for improving gastrointestinal function
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
IN2012DN02177A (da)
IN2012DN02702A (da)
IN2012DN00754A (da)
GB201106743D0 (en) Novel compounds
MY162146A (en) Pharmaceutical composition
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2015161243A3 (en) Beta-lactamases with improved properties for therapy